guancydine

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1978
1978
A variety of N-alkyl-N'-pyridyl-N"-cyanoguanidines III was prepared as potential bioisosteres of hypotensive N-alkyl-N… (More)
Is this relevant?
1977
1977
Guancydine (1-cyano-3-tert-amylguanidine) lowered within normal limits the tensional values in an interval of four hours after… (More)
Is this relevant?
1977
1977
The effect of guancydine (1-cyano-3-tert-amylguanidine) on systemic and renal hemodynamics was studied in nine patients with… (More)
Is this relevant?
1975
1975
Adequate treatment of hypertension requires that the physician understand the pharmacologic actions of antihypertensive agents… (More)
Is this relevant?
1972
1972
Guancydine was administered to 10 patients for a period of 3 weeks to 6 months. The drug produced a decrease in both supine and… (More)
Is this relevant?
1971
1971
SummaryGuancydine, a new antihypertensive agent, was given orally in divided doses up to 1000 mg a day, to five male in-patients… (More)
  • table I
  • table 2
Is this relevant?
1971
1971
SummaryOral administration of a single 500 mg dose of guancydine rapidly (30 mins) produces a marked fall in systolic and… (More)
  • table 1
  • table 1
  • table 3
  • figure 2
  • table 4
Is this relevant?
1971
1971
The hypotensive effects of guancydine (1-cyano-3- tert. -amylguanidine) were attributed by Cummings et at. (J. Pharmacol. Exp… (More)
Is this relevant?
1969
1969
Infusions of graded amounts of angiotensin to rats evoked a sustained dose-related elevation in mean blood pressure. Oral… (More)
Is this relevant?
1968
1968
In conscious normotensive rats, oral administrations of guancydine caused a dose-related hypotension and bradycardia. Vasopressor… (More)
Is this relevant?